Viewing Study NCT00083005


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2025-12-26 @ 2:02 AM
Study NCT ID: NCT00083005
Status: COMPLETED
Last Update Posted: 2012-03-15
First Post: 2004-05-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate
Sponsor: National Institutes of Health Clinical Center (CC)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module